Listed

Nautilus Biotechnology, Inc.

NAUTNasdaqCIK 1808805TechnologyFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$234.0k, Q3 FY2026
Net income−$15.6m, Q3 FY2026
Nautilus Biotechnology, Inc., income statement, quarterly
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reported0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figurenot reportednot reported0.2Revenue, Q2 FY2026, three months to 2026-06-30$190.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure0.2Revenue, Q3 FY2026, three months to 2026-09-30$234.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reported0.0Cost of revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure0.0Cost of revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figurenot reportednot reported0.0Cost of revenue, Q2 FY2026, three months to 2026-06-30$15.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure0.0Cost of revenue, Q3 FY2026, three months to 2026-09-30$24.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure
Research and development$m12.5Research and development, Q4 FY2023, three months to 2023-12-31$12.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-02-27, accession 0001808805-25-000008. Derived: 12-month figure less the 9-month figure.Report this figure12.9Research and development, Q1 FY2024, three months to 2024-03-31$12.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-04-29, accession 0001808805-25-000042.Report this figure12.4Research and development, Q2 FY2024, three months to 2024-06-30$12.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-31, accession 0001808805-25-000072.Report this figure12.3Research and development, Q3 FY2024, three months to 2024-09-30$12.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-28, accession 0001808805-25-000080.Report this figure12.8Research and development, Q4 FY2024, three months to 2024-12-31$12.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001808805-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure11.5Research and development, Q1 FY2025, three months to 2025-03-31$11.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure10.4Research and development, Q2 FY2025, three months to 2025-06-30$10.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure9.6Research and development, Q3 FY2025, three months to 2025-09-30$9.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure9.6Research and development, Q4 FY2025, three months to 2025-12-31$9.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001808805-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure9.7Research and development, Q1 FY2026, three months to 2026-03-31$9.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure9.6Research and development, Q2 FY2026, three months to 2026-06-30$9.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure10.2Research and development, Q3 FY2026, three months to 2026-09-30$10.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure
Selling, general and administrative$mnot reportednot reportednot reportednot reportednot reported7.3Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$7.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure6.7Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$6.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure5.9Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$5.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figurenot reported6.4Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$6.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure6.3Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$6.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure6.8Selling, general and administrative, Q3 FY2026, three months to 2026-09-30$6.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure
Operating income$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-02-27, accession 0001808805-25-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-04-29, accession 0001808805-25-000042.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-31, accession 0001808805-25-000072.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-28, accession 0001808805-25-000080.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001808805-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001808805-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure0.0Income tax, Q3 FY2026, three months to 2026-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure
Net income$m(17.0)Net income, Q4 FY2023, three months to 2023-12-31−$17.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-27, accession 0001808805-25-000008. Derived: 12-month figure less the 9-month figure.Report this figure(18.7)Net income, Q1 FY2024, three months to 2024-03-31−$18.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-04-29, accession 0001808805-25-000042.Report this figure(18.0)Net income, Q2 FY2024, three months to 2024-06-30−$18.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-07-31, accession 0001808805-25-000072.Report this figure(16.4)Net income, Q3 FY2024, three months to 2024-09-30−$16.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0001808805-25-000080.Report this figure(17.6)Net income, Q4 FY2024, three months to 2024-12-31−$17.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001808805-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(16.6)Net income, Q1 FY2025, three months to 2025-03-31−$16.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure(15.0)Net income, Q2 FY2025, three months to 2025-06-30−$15.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure(13.6)Net income, Q3 FY2025, three months to 2025-09-30−$13.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure(13.8)Net income, Q4 FY2025, three months to 2025-12-31−$13.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001808805-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(14.7)Net income, Q1 FY2026, three months to 2026-03-31−$14.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure(14.5)Net income, Q2 FY2026, three months to 2026-06-30−$14.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure(15.6)Net income, Q3 FY2026, three months to 2026-09-30−$15.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure
Diluted EPS$ per sharenot reported(0.15)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-04-29, accession 0001808805-25-000042.Report this figure(0.14)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-31, accession 0001808805-25-000072.Report this figure(0.13)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-28, accession 0001808805-25-000080.Report this figurenot reported(0.13)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure(0.12)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure(0.11)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figurenot reported(0.12)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure(0.11)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure(0.12)Diluted EPS, Q3 FY2026, three months to 2026-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure
Basic EPS$ per sharenot reported(0.15)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-04-29, accession 0001808805-25-000042.Report this figure(0.14)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-31, accession 0001808805-25-000072.Report this figure(0.13)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-28, accession 0001808805-25-000080.Report this figurenot reported(0.13)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure(0.12)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure(0.11)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figurenot reported(0.12)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure(0.11)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure(0.12)Basic EPS, Q3 FY2026, three months to 2026-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure

Balance sheet

Cash and equivalents$10.5m, Q3 FY2026
Shareholders' equity$116.6m, Q3 FY2026
Nautilus Biotechnology, Inc., balance sheet, quarterly
Line itemUnitFY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Cash and equivalents$m19.4Cash and equivalents, FY2023, at 2023-12-31$19.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-27, accession 0001808805-25-000008.Report this figure25.7Cash and equivalents, Q1 FY2024, at 2024-03-31$25.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-04-30, accession 0001808805-24-000041.Report this figure24.9Cash and equivalents, Q2 FY2024, at 2024-06-30$24.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-07-30, accession 0001808805-24-000058.Report this figure4.4Cash and equivalents, Q3 FY2024, at 2024-09-30$4.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-29, accession 0001808805-24-000072.Report this figure27.6Cash and equivalents, FY2024, at 2024-12-31$27.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001808805-26-000011.Report this figure33.2Cash and equivalents, Q1 FY2025, at 2025-03-31$33.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-04-29, accession 0001808805-25-000042.Report this figure34.5Cash and equivalents, Q2 FY2025, at 2025-06-30$34.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-31, accession 0001808805-25-000072.Report this figure23.9Cash and equivalents, Q3 FY2025, at 2025-09-30$23.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-28, accession 0001808805-25-000080.Report this figure12.4Cash and equivalents, FY2025, at 2025-12-31$12.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure14.6Cash and equivalents, Q1 FY2026, at 2026-03-31$14.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure13.2Cash and equivalents, Q2 FY2026, at 2026-06-30$13.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure10.5Cash and equivalents, Q3 FY2026, at 2026-09-30$10.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure
Current assets$m177Current assets, FY2023, at 2023-12-31$176.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0001808805-25-000008.Report this figure185Current assets, Q1 FY2024, at 2024-03-31$185.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-04-30, accession 0001808805-24-000041.Report this figure171Current assets, Q2 FY2024, at 2024-06-30$170.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-07-30, accession 0001808805-24-000058.Report this figure144Current assets, Q3 FY2024, at 2024-09-30$144.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-29, accession 0001808805-24-000072.Report this figure133Current assets, FY2024, at 2024-12-31$132.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001808805-26-000011.Report this figure142Current assets, Q1 FY2025, at 2025-03-31$141.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-04-29, accession 0001808805-25-000042.Report this figure151Current assets, Q2 FY2025, at 2025-06-30$150.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-31, accession 0001808805-25-000072.Report this figure134Current assets, Q3 FY2025, at 2025-09-30$134.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-28, accession 0001808805-25-000080.Report this figure106Current assets, FY2025, at 2025-12-31$106.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure98.8Current assets, Q1 FY2026, at 2026-03-31$98.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure87.6Current assets, Q2 FY2026, at 2026-06-30$87.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure90.2Current assets, Q3 FY2026, at 2026-09-30$90.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure
Total assets$m306Total assets, FY2023, at 2023-12-31$305.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0001808805-25-000008.Report this figure289Total assets, Q1 FY2024, at 2024-03-31$288.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-04-30, accession 0001808805-24-000041.Report this figure273Total assets, Q2 FY2024, at 2024-06-30$272.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-07-30, accession 0001808805-24-000058.Report this figure260Total assets, Q3 FY2024, at 2024-09-30$259.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-29, accession 0001808805-24-000072.Report this figure243Total assets, FY2024, at 2024-12-31$242.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001808805-26-000011.Report this figure228Total assets, Q1 FY2025, at 2025-03-31$227.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-04-29, accession 0001808805-25-000042.Report this figure213Total assets, Q2 FY2025, at 2025-06-30$213.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-31, accession 0001808805-25-000072.Report this figure201Total assets, Q3 FY2025, at 2025-09-30$200.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-28, accession 0001808805-25-000080.Report this figure191Total assets, FY2025, at 2025-12-31$191.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure178Total assets, Q1 FY2026, at 2026-03-31$177.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure164Total assets, Q2 FY2026, at 2026-06-30$163.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure149Total assets, Q3 FY2026, at 2026-09-30$148.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure
Current liabilities$m9.1Current liabilities, FY2023, at 2023-12-31$9.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0001808805-25-000008.Report this figure9.2Current liabilities, Q1 FY2024, at 2024-03-31$9.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-04-30, accession 0001808805-24-000041.Report this figure8.7Current liabilities, Q2 FY2024, at 2024-06-30$8.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-07-30, accession 0001808805-24-000058.Report this figure8.7Current liabilities, Q3 FY2024, at 2024-09-30$8.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-29, accession 0001808805-24-000072.Report this figure7.6Current liabilities, FY2024, at 2024-12-31$7.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001808805-26-000011.Report this figure8.2Current liabilities, Q1 FY2025, at 2025-03-31$8.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-04-29, accession 0001808805-25-000042.Report this figure8.1Current liabilities, Q2 FY2025, at 2025-06-30$8.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-31, accession 0001808805-25-000072.Report this figure9.0Current liabilities, Q3 FY2025, at 2025-09-30$9.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-28, accession 0001808805-25-000080.Report this figure8.0Current liabilities, FY2025, at 2025-12-31$8.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure8.3Current liabilities, Q1 FY2026, at 2026-03-31$8.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure8.6Current liabilities, Q2 FY2026, at 2026-06-30$8.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure9.8Current liabilities, Q3 FY2026, at 2026-09-30$9.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure
Total liabilities$m40.2Total liabilities, FY2023, at 2023-12-31$40.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-27, accession 0001808805-25-000008.Report this figure39.2Total liabilities, Q1 FY2024, at 2024-03-31$39.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-04-30, accession 0001808805-24-000041.Report this figure37.5Total liabilities, Q2 FY2024, at 2024-06-30$37.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-07-30, accession 0001808805-24-000058.Report this figure36.3Total liabilities, Q3 FY2024, at 2024-09-30$36.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-29, accession 0001808805-24-000072.Report this figure34.0Total liabilities, FY2024, at 2024-12-31$34.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001808805-26-000011.Report this figure33.3Total liabilities, Q1 FY2025, at 2025-03-31$33.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-04-29, accession 0001808805-25-000042.Report this figure32.1Total liabilities, Q2 FY2025, at 2025-06-30$32.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-31, accession 0001808805-25-000072.Report this figure31.8Total liabilities, Q3 FY2025, at 2025-09-30$31.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-28, accession 0001808805-25-000080.Report this figure34.1Total liabilities, FY2025, at 2025-12-31$34.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure33.4Total liabilities, Q1 FY2026, at 2026-03-31$33.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure32.5Total liabilities, Q2 FY2026, at 2026-06-30$32.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure32.4Total liabilities, Q3 FY2026, at 2026-09-30$32.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure
Shareholders' equity$m265Shareholders' equity, FY2023, at 2023-12-31$265.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001808805-26-000011.Report this figure249Shareholders' equity, Q1 FY2024, at 2024-03-31$249.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-07-31, accession 0001808805-25-000072.Report this figure235Shareholders' equity, Q2 FY2024, at 2024-06-30$235.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0001808805-25-000080.Report this figure223Shareholders' equity, Q3 FY2024, at 2024-09-30$223.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0001808805-25-000080.Report this figure209Shareholders' equity, FY2024, at 2024-12-31$208.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure194Shareholders' equity, Q1 FY2025, at 2025-03-31$194.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure181Shareholders' equity, Q2 FY2025, at 2025-06-30$181.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure169Shareholders' equity, Q3 FY2025, at 2025-09-30$169.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure157Shareholders' equity, FY2025, at 2025-12-31$157.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure144Shareholders' equity, Q1 FY2026, at 2026-03-31$144.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure131Shareholders' equity, Q2 FY2026, at 2026-06-30$131.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure117Shareholders' equity, Q3 FY2026, at 2026-09-30$116.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure

Cash flow

Operating cash flow−$13.3m, Q3 FY2026
Capital expenditure$1.4m, Q3 FY2026
Nautilus Biotechnology, Inc., cash flow, quarterly
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Operating cash flow$m(13.9)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$13.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-27, accession 0001808805-25-000008. Derived: 12-month figure less the 9-month figure.Report this figure(16.3)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$16.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-04-29, accession 0001808805-25-000042.Report this figure(15.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$15.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-31, accession 0001808805-25-000072. Derived: 6-month figure less the 3-month figure.Report this figure(13.1)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$13.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-28, accession 0001808805-25-000080. Derived: 9-month figure less the 6-month figure.Report this figure(14.3)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$14.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001808805-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(13.9)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$13.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure(13.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$13.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-28, accession 0001808805-26-000034. Derived: 6-month figure less the 3-month figure.Report this figure(11.0)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$11.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-27, accession 0001808805-26-000052. Derived: 9-month figure less the 6-month figure.Report this figure(12.4)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$12.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001808805-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(13.1)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$13.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure(13.7)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$13.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-28, accession 0001808805-26-000034. Derived: 6-month figure less the 3-month figure.Report this figure(13.3)Operating cash flow, Q3 FY2026, three months to 2026-09-30−$13.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-27, accession 0001808805-26-000052. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$m0.4Capital expenditure, Q4 FY2023, three months to 2023-12-31$413.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-27, accession 0001808805-25-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.6Capital expenditure, Q1 FY2024, three months to 2024-03-31$647.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-04-29, accession 0001808805-25-000042.Report this figure0.5Capital expenditure, Q2 FY2024, three months to 2024-06-30$512.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-31, accession 0001808805-25-000072. Derived: 6-month figure less the 3-month figure.Report this figure0.7Capital expenditure, Q3 FY2024, three months to 2024-09-30$709.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-28, accession 0001808805-25-000080. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, Q4 FY2024, three months to 2024-12-31$254.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001808805-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2025, three months to 2025-03-31$219.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure0.4Capital expenditure, Q2 FY2025, three months to 2025-06-30$396.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-28, accession 0001808805-26-000034. Derived: 6-month figure less the 3-month figure.Report this figure0.4Capital expenditure, Q3 FY2025, three months to 2025-09-30$418.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-27, accession 0001808805-26-000052. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$244.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001808805-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.5Capital expenditure, Q1 FY2026, three months to 2026-03-31$510.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure0.5Capital expenditure, Q2 FY2026, three months to 2026-06-30$454.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-28, accession 0001808805-26-000034. Derived: 6-month figure less the 3-month figure.Report this figure1.4Capital expenditure, Q3 FY2026, three months to 2026-09-30$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-27, accession 0001808805-26-000052. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)127.24m, Q3 FY2026
Nautilus Biotechnology, Inc., shares, quarterly
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Diluted shares (weighted)m shares125Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31124,590,351 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-04-30, accession 0001808805-24-000041.Report this figure125Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30124,603,181 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-07-30, accession 0001808805-24-000058.Report this figure125Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30124,933,837 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-29, accession 0001808805-24-000072.Report this figure125Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31125,135,451 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-04-29, accession 0001808805-25-000042.Report this figure125Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30125,317,650 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-31, accession 0001808805-25-000072.Report this figure125Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30125,452,572 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-28, accession 0001808805-25-000080.Report this figure126Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31126,144,240 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure126Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30126,204,632 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure126Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30126,305,122 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure127Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31126,634,782 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-28, accession 0001808805-26-000022.Report this figure127Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30127,135,738 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-28, accession 0001808805-26-000034.Report this figure127Diluted shares (weighted), Q3 FY2026, three months to 2026-09-30127,238,065 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure

Shares outstanding: 127.37mShares outstanding, period not labelled, at 2026-10-22127,372,425 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-10-27, accession 0001808805-26-000052.Report this figure at Oct 22, 2026, from the cover of the 10-Q filed Oct 27, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 07:43 ET. Listed shows no prices and gives no investment advice.